Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps

J Bai, JH Huang, CPE Price, JM Schauer… - Journal of Allergy and …, 2022 - Elsevier
Background Chronic rhinosinusitis with nasal polyps is frequently managed with endoscopic
sinus surgery (ESS). Prior studies describe individual clinical variables and eosinophil …

Management of united airway disease focused on patients with asthma and chronic rhinosinusitis with nasal polyps: a systematic review

J Mullol, M Maldonado, JA Castillo… - The Journal of Allergy …, 2022 - Elsevier
Background The clinical approach to upper and lower respiratory diseases from a joint
perspective, known as united airways disease (UAD), is challenging for health care …

Treatment options for chronic rhinosinusitis with nasal polyps.

DV Wallace - Allergy & Asthma Proceedings, 2021 - search.ebscohost.com
Background: The management of chronic rhinosinusitis with nasal polyps (CRSwNP) is
evolving, with an emphasis on treating the underlying type 2 inflammation. Objective: The …

The role of biologics in the treatment of chronic rhinosinusitis

N Haloob, K Karamali, C Hopkins - BioDrugs, 2023 - Springer
The last decade has seen significant developments in the field of biologics for the treatment
of chronic rhinosinusitis with nasal polyps (CRSwNP). Translational research borne from …

Considerations for shared decision-making in treatment of chronic rhinosinusitis with nasal polyps

SP Ramkumar, D Lal, A Miglani - Frontiers in Allergy, 2023 - frontiersin.org
Shared decision-making is an approach where physicians and patients work together to
determine a personalized treatment course. Such an approach is integral to patient-centered …

Biologics for nasal polyps: synthesizing current recommendations into a practical clinical algorithm

NR Godse, A Keswani, AP Lane… - American Journal of …, 2023 - journals.sagepub.com
Background Chronic rhinosinusitis with nasal polyps (CRSwNP) has been traditionally
managed with a combination of topical and systemic medical therapy as well as endoscopic …

Chronic rhinosinusitis with nasal polyposis treated with dupilumab: real-world use and outcomes

IL Schmale, A Poulakis, A Abend, ME Luitje… - The Journal of Allergy …, 2023 - Elsevier
Background Biologic medications are increasingly incorporated into chronic rhinosinusitis
with nasal polyps (CRSwNP) management. However, little is known about prescribing …

[HTML][HTML] Review of evidence supporting the use of nasal corticosteroid irrigation for chronic rhinosinusitis

JA Bernstein, AA White, JK Han, DM Lang… - Annals of Allergy …, 2023 - Elsevier
Objective To analyze published reports on the efficacy and safety of CSI in CRS and
evaluate the clinical implications of current gaps in evidence. Corticosteroid irrigation (CSI) …

Should Biologics Be Used Before Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease (AERD)?

TM Laidlaw, AA White - The Journal of Allergy and Clinical Immunology: In …, 2023 - Elsevier
Should Biologics Be Used Before Aspirin Desensitization in Aspirin-Exacerbated Respiratory
Disease (AERD)? Page 1 Journal Pre-proof Should Biologics Be Used Before Aspirin …

The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP)

SA Hardison, BA Senior - Journal of Otolaryngology-Head & …, 2023 - journals.sagepub.com
Dupilumab and other biologics have revolutionized the management of recalcitrant polyps in
patients with chronic rhinosinusitis with nasal polyposis (CRSwNP). Despite strong evidence …